28 Apr 2008 Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
28 Apr 2008 KaloBios Completes Patient Dosing in its U.S. Phase 1 Trial of Its Third Drug Candidate, KB003
28 Apr 2008 Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
24 Apr 2008 ESBATech's Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
24 Apr 2008 MorphoSys and the Leibniz-Institut für Molekulare Pharmakologie Sign Broad Research Partnership
24 Apr 2008 Arana and Kyowa Hakko to co-develop anti-cancer drug
24 Apr 2008 Micromet Enrolls First Patient in Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
23 Apr 2008 ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer
23 Apr 2008 Single, Intramuscular (IM) Dose, Protects up to 75 Percent in Primate Study
23 Apr 2008 CimziaA(R) Approved in the US for the Treatment of Moderate to Severe Crohn's Disease
22 Apr 2008 Human Genome Sciences completes enrollment in first of two phase 3 LYMPHOSTAT-B(R) trials
21 Apr 2008 Cancer Treatment Pioneer, Lpath, Initiates Dosing in Phase 1 Cancer Trial
21 Apr 2008 Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
20 Apr 2008 Genentech Provides Update on "AVAiL" Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer
17 Apr 2008 Actemra approved in Japan to treat patients with rheumatoid arthritis
16 Apr 2008 Medarex Reports Preclinical Data on Multiple Antibody-Drug Conjugate Candidates at American Association for Cancer Research Meeting
16 Apr 2008 Data presented at the 60th Annual Meeting of the American Academy of Neurology offers additional support for plasma exchange as a potential tool to accelerate Tysabri (R) removal
16 Apr 2008 HUMIRA(R) received approval for the treatment of rheumatoid arthritis in Japan
16 Apr 2008 Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting
16 Apr 2008 Human Genome Sciences Advances Oncology Portfolio
15 Apr 2008 Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
15 Apr 2008 MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
15 Apr 2008 Seattle Genetics Presents Preclinical Data on its Antibody-Drug Conjugate Technology and SGN-33 Program at AACR
15 Apr 2008 Preclinical data presented for Active Biotech's ANYARA technology
15 Apr 2008 Preclinical Study Presented at AACR Annual Meeting Shows Peregrine's Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up